GPAT4 and ovarian carcinoma: As an individual indicator, GPAT4 exhibited a strong predictive capability for drug resistance in ovarian cancer (GPAT4 IHC score AUC 0.917, GPAT4 expression group AUC 0.874, Table S4, Figure 4F).